Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

60
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
60
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

16
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
16
The Citric Acid Cycle: Overview01:37

The Citric Acid Cycle: Overview

18.1K
In aerobic organisms, the citric acid cycle is the second stage of cellular respiration wherein molecules derived from the breakdown of carbohydrates, proteins, and fats are oxidized into carbon dioxide and energy. This process is also known as the tricarboxylic acid (TCA) cycle as the first product of the cycle, citric acid, contains three carboxyl groups in its structure. Alternatively, this cycle is also referred to as the Krebs cycle, in honor of its discoverer Sir Hans Krebs.
The citric...
18.1K
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

10
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
10
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

1.5K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.5K
Pyruvate Oxidation01:15

Pyruvate Oxidation

160.0K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
160.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current perspectives on the pathogenesis of multiple sclerosis: A minireview.

Endocrine regulations·2026
Same author

Dance and Dietary Intervention Improves Metabolic Health, Fitness, and Quality of Life With Modest Gut Microbiota Shifts in Breast Cancer Patients With Obesity: A Pilot RCT.

Cancer reports (Hoboken, N.J.)·2026
Same author

Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.

Neurology and therapy·2026
Same author

Skeletal muscle mitochondrial impairment in patients with newly diagnosed multiple sclerosis revealed by ¹H/³¹P magnetic resonance spectroscopy.

Scientific reports·2026
Same author

Integrating artificial intelligence tools in health research.

NPJ digital medicine·2026
Same author

Effects of Positive Airway Pressure Therapy on Cognitive Function in Patients with Obstructive Sleep Apnea: A Prospective Observational Study Protocol.

Life (Basel, Switzerland)·2026

Related Experiment Video

Updated: Aug 5, 2025

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

13.2K

Nutritional interventions for patients with alkaptonuria: A minireview.

Richard Imrich1,2, Andrea Zatkova1, Olga Lukacova2

  • 11Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.

Endocrine Regulations
|March 26, 2023
PubMed
Summary

Alkaptonuria treatment with nitisinone reduces homogentisic acid but causes hypertyrosinemia. Novel nutritional strategies are needed to manage side effects and protect muscle health in AKU patients.

Keywords:
alkaptonurianitisinonenutritional intervention

More Related Videos

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

8.4K
Extraction of Non-Protein Amino Acids from Cyanobacteria for Liquid Chromatography-Tandem Mass Spectrometry Analysis
08:14

Extraction of Non-Protein Amino Acids from Cyanobacteria for Liquid Chromatography-Tandem Mass Spectrometry Analysis

Published on: December 9, 2022

3.8K

Related Experiment Videos

Last Updated: Aug 5, 2025

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

13.2K
Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

8.4K
Extraction of Non-Protein Amino Acids from Cyanobacteria for Liquid Chromatography-Tandem Mass Spectrometry Analysis
08:14

Extraction of Non-Protein Amino Acids from Cyanobacteria for Liquid Chromatography-Tandem Mass Spectrometry Analysis

Published on: December 9, 2022

3.8K

Area of Science:

  • Biochemistry
  • Metabolic disorders
  • Genetics

Background:

  • Alkaptonuria (AKU) is a rare genetic disorder caused by homogentisate 1,2-dioxygenase deficiency, leading to homogentisic acid accumulation and ochronosis.
  • AKU causes severe joint problems, fractures, and osteoporosis.
  • Nitisinone, approved in 2020, effectively reduces homogentisic acid but induces hypertyrosinemia.

Purpose of the Study:

  • To address the adverse effects of nitisinone-induced hypertyrosinemia in AKU patients.
  • To explore novel nutritional approaches for managing AKU treatment complications.
  • To mitigate the negative impact on skeletal muscle metabolism.

Main Methods:

  • Review of nitisinone's mechanism and side effects in AKU.
  • Analysis of dietary interventions for hypertyrosinemia.
  • Evaluation of nutritional impacts on muscle metabolism in AKU.

Main Results:

  • Nitisinone treatment significantly lowers homogentisic acid levels.
  • Hypertyrosinemia is a key side effect, potentially causing corneal keratopathy.
  • Low-protein diets, while reducing keratopathy risk, lead to poor tolerance, muscle loss, and weight gain.

Conclusions:

  • Nitisinone is effective for AKU but poses risks due to hypertyrosinemia.
  • Current dietary management is challenging and detrimental to muscle health.
  • Development of new nutritional strategies is crucial for AKU patients on nitisinone.